Mon Dec 31, 2012 1:54pm EST
(Reuters) – U.S. health regulators authorized Salix Pharmaceuticals Ltd’s drug to provide diarrhea in HIV/AIDS patients on antiretroviral therapy, a multiple of medicines used to provide HIV infection.
Diarrhea is a common reason because HIV/AIDS patients pause or switch their antiretroviral therapies.
The drug, called Fulyzaq, is dictated to be used in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite.
Until now, there have been no therapies for HIV-associated diarrhea authorized by a U.S. Food and Drug Administration.
(Reporting By Debra Sherman; Editing by David Gregorio)
More on: Health Medicine Network